abstract |
Provided herein are alanyl-glutamine (Ala-Gln) formulations for use in treating and preventing side effects associated with cancer treatment. Also provided herein are methods of using the formulations provided herein to treat or prevent side effects associated with cancer treatment. [Selection] Figure 1 |